EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptional activation of endogenous Oct4 via the CRISPR / dCas9 activator ameliorates Hutchinson‐Gilford progeria syndrome in mice

Junyeop Kim, Yerim Hwang, Sumin Kim, Yujung Chang, Yunkyung Kim, Youngeun Kwon, Jongpil Kim iD

Aging Cell · 2023

DOI: 10.1111/acel.13825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2023. Verfasst von Junyeop Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Stem Cells & Cell reprogramming, Department of Chemistry, Dongguk University, 100-715, Seoul, Korea. Hauptthemen laut MEDLINE: Progeria. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Partial cellular reprogramming via transient expression of Oct4, Sox2, Klf4, and c‐Myc induces rejuvenation and reduces aged‐cell phenotypes. In this study, we found that transcriptional activation of the endogenous Oct4 gene by using the CRISPR/dCas9 activator system can efficiently ameliorate hallmarks of aging in a mouse model of Hutchinson‐Gilford progeria syndrome (HGPS). We observed that the dCas9‐Oct4 activator induced epigenetic remodeling, as evidenced by increased H3K9me3 and decreased H4K20me3 levels, without tumorization. Moreover, the progerin accumulation in HGPS aorta was significantly suppressed by the dCas9 activator‐mediated Oct4 induction. Importantly, CRISPR/dCas9‐activated Oct4 expression rescued the HGPS‐associated vascular pathological features and lifespan shortening in the mouse model. These results suggest that partial rejuvenation via CRISPR/dCas9‐mediated Oct4 activation can be used as a novel strategy in treating geriatric diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgeriaMiceAnimalsTranscriptional ActivationClustered Regularly Interspaced Short Palindromic RepeatsAgingCellular ReprogrammingDisease Models, AnimalLamin Type A

Stichwörter der Autor:innen

CRISPR/dCas9Hutchinson-Gilford progeria syndromeOct4agingrejuvenation

Substanzen

Lamin Type A

Autor:innen und Institutionen

  • Laboratory of Stem Cells & Cell reprogramming, Department of Chemistry, Dongguk University, 100-715, Seoul, Korea.
  • Laboratory of Protein Engineering, Department of Biomedical Engineering, Dongguk University, 04620, Seoul, Korea.

ORCID-Profile: Jongpil Kim

Förderung

  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea

Zitieren

APA

Kim, J., Hwang, Y., Kim, S., Chang, Y., Kim, Y., Kwon, Y., & Kim, J. (2023). Transcriptional activation of endogenous Oct4 via the CRISPR / dCas9 activator ameliorates Hutchinson‐Gilford progeria syndrome in mice. Aging Cell. https://doi.org/10.1111/acel.13825

Vancouver

Kim J, Hwang Y, Kim S, Chang Y, Kim Y, Kwon Y, et al. Transcriptional activation of endogenous Oct4 via the CRISPR / dCas9 activator ameliorates Hutchinson‐Gilford progeria syndrome in mice. Aging Cell. 2023. doi:10.1111/acel.13825

BibTeX
@article{Kim2023,
  author = {Kim, Junyeop and Hwang, Yerim and Kim, Sumin and Chang, Yujung and Kim, Yunkyung and Kwon, Youngeun and Kim, Jongpil},
  title = {Transcriptional activation of endogenous Oct4 via the CRISPR / dCas9 activator ameliorates Hutchinson‐Gilford progeria syndrome in mice},
  journal = {Aging Cell},
  year = {2023},
  doi = {10.1111/acel.13825}
}
Kostenlos starten →